216 related articles for article (PubMed ID: 28423706)
1. Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach.
Gkretsi V; Stylianou A; Louca M; Stylianopoulos T
Oncotarget; 2017 Apr; 8(16):27364-27379. PubMed ID: 28423706
[TBL] [Abstract][Full Text] [Related]
2. Depletion of Ras Suppressor-1 (RSU-1) promotes cell invasion of breast cancer cells through a compensatory upregulation of a truncated isoform.
Gkretsi V; Kalli M; Efstathiades C; Papageorgis P; Papanikolaou V; Zacharia LC; Tsezou A; Athanassiou E; Stylianopoulos T
Sci Rep; 2019 Jul; 9(1):10050. PubMed ID: 31296919
[TBL] [Abstract][Full Text] [Related]
3. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
4. Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, β-catenin and urokinase-plasminogen activator (uPA).
Gkretsi V; Stylianou A; Stylianopoulos T
Exp Cell Res; 2017 Mar; 352(2):281-292. PubMed ID: 28209486
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).
Gkretsi V; Louca M; Stylianou A; Minadakis G; Spyrou GM; Stylianopoulos T
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621163
[TBL] [Abstract][Full Text] [Related]
6. Ras suppressor 1 long form (RSU1L) silencing promotes apoptosis in invasive breast cancer cells.
Christou C; Christodoulou MI; Zaravinos A; Gkretsi V
Cell Signal; 2023 Jan; 101():110522. PubMed ID: 36375714
[TBL] [Abstract][Full Text] [Related]
7. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
8. Ras suppressor-1 (RSU-1) promotes cell invasion in aggressive glioma cells and inhibits it in non-aggressive cells through STAT6 phospho-regulation.
Louca M; Stylianou A; Minia A; Pliaka V; Alexopoulos LG; Gkretsi V; Stylianopoulos T
Sci Rep; 2019 May; 9(1):7782. PubMed ID: 31123330
[TBL] [Abstract][Full Text] [Related]
9. Scaffold stiffness influences breast cancer cell invasion via EGFR-linked Mena upregulation and matrix remodeling.
Berger AJ; Renner CM; Hale I; Yang X; Ponik SM; Weisman PS; Masters KS; Kreeger PK
Matrix Biol; 2020 Jan; 85-86():80-93. PubMed ID: 31323325
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
11. Ras Suppressor-1 (RSU-1) in Cancer Cell Metastasis: Friend or Foe?
Zacharia LC; Stylianopoulos T; Gkretsi V
Crit Rev Oncog; 2017; 22(3-4):249-253. PubMed ID: 29604901
[TBL] [Abstract][Full Text] [Related]
12. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
Tang L; Han X
Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
[TBL] [Abstract][Full Text] [Related]
13. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
Huang HY; Jiang ZF; Li QX; Liu JY; Wang T; Zhang R; Zhao J; Xu YM; Bao W; Zhang Y; Jia LT; Yang AG
Cancer Invest; 2010 Aug; 28(7):689-97. PubMed ID: 20636107
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
16. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
17. Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.
Zhang Y; Wei L; Yu J; Li G; Zhang X; Wang A; He Y; Li H; Yin D
Oncol Rep; 2014 Nov; 32(5):1787-95. PubMed ID: 25176506
[TBL] [Abstract][Full Text] [Related]
18. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.
Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M
FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903
[TBL] [Abstract][Full Text] [Related]
19. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
